Actinium's Four Presentations at ASH Highlight the Positive

Actinium's Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Actinium's Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , American , Sandesh Seth , Astellas Pharma , Oncology Lg Chem Life Sciences , Actimaba National Cancer Institute , Actinium Pharmaceuticals Inc , Prnewswire Actinium Pharmaceuticals Inc , American Society Of Hematology Annual Meeting Exposition , Exchange Commission , Annual American Society , Hematology Annual Meeting , Multiple High Risk , Complete Remission , Karnofsky Performance Status , Dose Targeted Radiation , Apamistamab Prior , Durable Complete Remission , Actinium Pharmaceuticals , National Cancer Institute , Life Sciences , Mutated Acute Myeloid Leukemia , Onco Targets ,